✦ LIBER ✦

PG19 COST-UTILITY-ANALYSIS OF PEGINTERFERON ALFA-2B PLUS RIBAVIRIN VERSUS INTERFERON ALFA-2B PLUS RIBAVIRIN AS INITIAL THERAPY FOR CHINESE NAIVE PATIENTS WITH CHRONIC HEPATITIS C

✍ Scribed by YH Tarn; WA Lin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon alfa-2b plus ribavirin com

✍ Michael P Manns; John G McHutchison; Stuart C Gordon; Vinod K Rustgi; Mitchell S 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 110 KB

PGI5 THE COST-EFFECTIVENESS OF PEGINTERF

✍ MC Fonseca; GTB Araujo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PIN31: THE COST-EFFECTIVENESS OF PEGINTE

✍ SD Sullivan; J Green; KK Patel; A Craxi; A Alberti; G Giuliani; C De Carli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Cost-effectiveness of peginterferon alph

✍ Uwe Siebert; Gaby Sroczynski; Siegbert Rossol; Juergen Wasem; Ulrike Ravens-Sieb 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 223 KB

P.260 Peginterferon alpha-2b plus ribavi

✍ R.M. El-Wakil; M.F. Montasser; M.A. Mansour; T.A. Salman; M.H. El-Batanony; E.H. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Cost–utility analysis of different peg-i

✍ W.-A. LIN; Y.-H. TARN; S.-L. TANG 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB